Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Influenza A m2 Inhibitors

Influenza A M2 inhibitors represent a distinctive chemical class of compounds that specifically target and inhibit the function of the M2 protein of the influenza A virus. The M2 protein is a transmembrane ion channel that plays a crucial role in the viral replication and uncoating process. By selectively inhibiting the activity of the M2 protein, these compounds aim to disrupt the virus's ability to release its genetic material into host cells, hindering viral replication and propagation.

Influenza A is a prevalent type of influenza virus that can cause seasonal flu outbreaks and occasional pandemics. The M2 protein is conserved among different strains of influenza A. Influenza A M2 inhibitors involves comprehensive investigations to determine their mode of action and their impact on viral replication and infectivity. Researchers explore the structural and functional aspects of the M2 protein and its interactions with other viral and host factors to uncover vulnerabilities that could be targeted by these inhibitors. The exploration of Influenza A M2 inhibitors extends beyond virology research. By gaining deeper insights into the molecular interactions that underlie the influenza A virus life cycle, scientists aim to contribute to the development of more effective strategies to combat influenza outbreaks and pandemics.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

1-Adamantylamine

768-94-5sc-251475
sc-251475A
1 g
25 g
$39.00
$147.00
(0)

Amantadine hydrochloride inhibits Influenza A M2 by blocking the proton channel activity of the protein. This inhibition disrupts the viral lifecycle, making it an effective antiviral agent against influenza A.

Rimantadine Hydrochloride

1501-84-4sc-205842
sc-205842A
25 mg
50 mg
$47.00
$104.00
(0)

Rimantadine Hydrochloride functions as an inhibitor of Influenza A M2 by impeding the proton channel activity of the protein. It obstructs proton influx and, consequently, viral uncoating.